SARS-CoV-2 Infection in Kidney Transplant Recipients: A Single-Centre Study of 20 Cases from India

Table 2

Clinical symptoms, treatment modalities, and outcomes of kidney transplant recipients with COVID-19.

Clinical symptoms	n (%)
Fever	20 (100%)
Cough	20 (100%)
Dyspnoea	11 (55%)
RT-PCR test COVID-19 positive	20 (100%)
Inpatient	12 (60%)
Telemedicine	8 (40%)
Immunosuppression
Tacrolimus	20 (100%)
Mycophenolate mofetil 50% dose reduction	7/18 (39%)
Mycophenolate mofetil withheld	11/18 (61%)
Azathioprine 50% dose reduction	1/2 (50%)
Azathioprine withheld	1/2 (50%)
Remdesivir	12 (60%)
Dexamethasone	12 (60%)
Oxygen supplementation
Mask	8 (40%)
Noninvasive ventilation (NIV)	1 (5%)
Mechanical	2 (10%)
Tocilizumab	3 (15%)
Outcome
Recovered	18 (90%)
Died	1 (5%)
In hospital	1 (5%)

General clinical symptoms observed in KTRs with COVID-19 infection, their treatment modalities, and the consequent treatment outcomes obtained are presented. n values and percentages of KTRs exhibiting each parameter are shown.